BARRECA, Maria Letizia
 Distribuzione geografica
Continente #
NA - Nord America 1.952
EU - Europa 1.430
AS - Asia 574
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
SA - Sud America 2
Totale 3.969
Nazione #
US - Stati Uniti d'America 1.930
IE - Irlanda 373
SE - Svezia 323
UA - Ucraina 280
CN - Cina 259
SG - Singapore 159
DE - Germania 155
VN - Vietnam 117
GB - Regno Unito 102
FI - Finlandia 78
IT - Italia 29
IN - India 27
RU - Federazione Russa 23
CA - Canada 21
CZ - Repubblica Ceca 18
BE - Belgio 14
FR - Francia 6
IR - Iran 6
PL - Polonia 6
AT - Austria 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CH - Svizzera 3
NL - Olanda 3
CL - Cile 2
EG - Egitto 2
NZ - Nuova Zelanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.969
Città #
Jacksonville 487
Dublin 373
Chandler 364
Nyköping 224
Ashburn 128
Singapore 128
Dong Ket 115
Beijing 114
Princeton 75
Cambridge 73
Medford 71
Des Moines 58
Boardman 50
Dearborn 41
Los Angeles 31
Lancaster 28
Ann Arbor 27
Woodbridge 27
Wilmington 19
Brno 18
Nanjing 18
Haikou 15
Jinan 15
Brussels 14
Ottawa 14
Hebei 12
Hyderabad 12
Shenyang 11
Taizhou 11
Washington 11
Saint Petersburg 10
Pune 9
San Mateo 9
Seattle 9
Munich 8
Zhengzhou 8
Hangzhou 7
Norwalk 7
Auburn Hills 6
Leawood 6
London 6
Tianjin 6
Warsaw 6
Ardabil 5
Riva 5
Taiyuan 5
Fuzhou 4
Monmouth Junction 4
Nanchang 4
Ningbo 4
Toronto 4
Tunis 4
West Jordan 4
Augusta 3
Brooklyn 3
Cormeilles-en-Parisis 3
Edinburgh 3
Frankfurt am Main 3
Lappeenranta 3
Mcallen 3
Milan 3
Montréal 3
New York 3
Sofia 3
Vienna 3
Amsterdam 2
Auckland 2
Bangalore 2
Cairo 2
Como 2
Dallas 2
Eden Prairie 2
Ferrara 2
Guangzhou 2
Helsinki 2
Houston 2
Kemerovo 2
Lanzhou 2
Manchester 2
Nanning 2
Novokuznetsk 2
Nuremberg 2
Pagani 2
Perugia 2
Albuquerque 1
Atlanta 1
Boston 1
Bratislava 1
Bucharest 1
Budapest 1
Cagliari 1
Catania 1
Changsha 1
Chicago 1
Clearwater 1
Copenhagen 1
Corleone 1
Cupertino 1
Dubai 1
Evanston 1
Totale 2.814
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 201
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 155
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 73
Anti-HIV agents: design and discovery of new potent RT inhibitors 71
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 69
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 66
Binding modes of noncompetitive AMPA antagonists: a computational approach 66
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 65
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 65
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 63
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 62
Computational studies of inhibitor resistance in HIV-1 integrase 62
Efficient 3D Database screening for novel HIV-1 IN inhibitors 61
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 60
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 60
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 60
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 60
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 59
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 57
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 56
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 56
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 56
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 55
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 55
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 54
Dynamic pharmacophore model development and testing 54
Design and synthesis of new HIV-1 NNRTIs 54
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 54
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 54
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 54
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 54
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 54
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 54
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 53
Pharmacophore-based design of HIV-1 integrase inhibitors 52
New trends in the development of AMPA receptor antagonists 52
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 52
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 51
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 51
Design and Synthesis of NR2B Subtype-Selective Antagonist 51
Synthesis of new potential HIV-1 integrase inhibitors 51
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 49
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 48
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 48
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 48
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 45
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 45
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 44
Molecular dynamics studies of the HIV-1 integrase 44
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 44
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 43
Molecular dynamics studies of the full-length integrase-DNA complex 42
Discovery of novel HIV-1 integrase inhibitors through computational strategies 42
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 42
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 42
Rational design and synthesis of novel NNRTI TBZ analogues 42
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 42
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 41
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 41
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 40
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 40
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 39
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 38
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 37
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 37
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 36
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 29
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 28
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 28
null 28
null 27
null 27
null 25
null 25
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 25
null 24
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 19
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 18
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 18
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 13
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 8
Totale 4.013
Categoria #
all - tutte 16.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020389 0 0 0 0 2 41 80 71 10 75 107 3
2020/2021597 74 0 105 15 7 68 1 69 1 79 48 130
2021/2022457 5 119 3 10 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024339 26 53 17 46 34 68 8 26 1 29 8 23
2024/2025219 20 35 49 101 14 0 0 0 0 0 0 0
Totale 4.013